The Society for Immunotherapy of Cancer (SITC) hosted this comprehensive cancer immunotherapy program, in Mesa, Ariz., Feb. 18–22, 2019. Taught by leading experts, this five-day program provided attendees a deep understanding of the core principles of tumor immunology and cancer immunotherapy and examined developing areas in the field.
Tailored to early career scientists and clinicians in the field, the program covered the fundamentals of cancer immunotherapy and allowed participants to tailor their experience by selecting the track most relevant to their educational goals.
Over the course of the week, attendees learned about:
In addition to deepening their understanding, attendees benefitted from professional development while interacting with faculty and thought leaders in this intimate setting.
The SITC Cancer Immunotherapy Winter School was supported in part by grants from Abbvie, AstraZeneca Pharmaceuticals LP, Celgene Corporation, Merck & Co., Inc and Prometheus Laboratories Inc.
SITC awarded travel reimbursement to five early career scientists who showed attendance at this program would help them reach their current and future cancer immunotherapy career objectives. Those honored with Cancer Immunotherapy Winter School Travel Awards include:
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com